Jennifer R. Cochran serves as Executive at LIGAND PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Jennifer R. Cochran has executed 11 insider transactions totaling $176.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 12, 2024 involved exercising options for 1,896 shares valued at $0.
Jennifer R. Cochran currently holds 115,274 shares of LIGAND PHARMACEUTICALS INC (LGND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jennifer R. Cochran has been a net buyer of LGND stock. They have purchased $176.4K and sold $0 worth of shares.
Jennifer R. Cochran's most recent insider trade was on Jul 12, 2024, when they sold 1,896 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 20,000 |
| $N/A |
| Discretionary |
| Jul 12, 2023 | OABI | $0 | Option Exercise | 1,896 | $N/A | Discretionary |
| Jan 30, 2023 | OABI | $0 | Award | 17,506 | $N/A | Discretionary |
| Dec 6, 2022 | OABI | $83.4K | Purchase | 22,250 | $3.75 | Discretionary |
| Nov 11, 2022 | OABI | $93.0K | Purchase | 30,000 | $3.10 | Discretionary |
| Nov 1, 2022 | OABI | $0 | Award | 25,518 | $N/A | Discretionary |
| Nov 1, 2022 | LGND | $0 | Disposition | 1,004 | $N/A | Discretionary |
| Nov 1, 2022 | OABI | $0 | Award | 25,226 | $N/A | Discretionary |
| Jun 10, 2022 | LGND | $0 | Award | 1,004 | $N/A | Discretionary |
| Jul 12, 2021 | LGND | $0 | Award | 1,161 | $N/A | Discretionary |